Pictet & Cie (Europe) Sa Pacific Biosciences Of California, Inc. Transaction History

Pictet & Cie (Europe) Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$4.02 - $10.43 $107,691 - $279,409	-26,789 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$8.43 - $20.9 $20,198 - $50,076	2,396 Added 9.82%	26,789 $244,000
Q4 2021 Feb 02, 2022	BUY	$19.26 - $30.08 $174,341 - $272,284	9,052 Added 59.01%	24,393 $499,000
Q3 2021 Nov 10, 2021	BUY	$24.86 - $35.02 $54,716 - $77,079	2,201 Added 16.75%	15,341 $392,000
Q2 2021 Aug 11, 2021	BUY	$22.3 - $36.02 $42,548 - $68,726	1,908 Added 16.99%	13,140 $460,000
Q1 2021 May 10, 2021	BUY	$26.38 - $51.15 $296,300 - $574,516	11,232 New	11,232 $374,000

256

226M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $351M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.